Literature DB >> 21660535

Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.

James D Chalmers1, Pallavi Mandal, Aran Singanayagam, Ahsan R Akram, Gourab Choudhury, Philip M Short, Adam T Hill.   

Abstract

BACKGROUND: The aim of this meta-analysis was to determine if severity assessment tools can be used to guide decisions regarding intensive care unit (ICU) admission of patients with community-acquired pneumonia.
METHODS: A search of PUBMED and EMBASE (1980-2009) was conducted to identify studies reporting pneumonia severity scores and prediction of ICU admission. Two reviewers independently collected data and assessed study quality. Performance characteristics were pooled using a random-effects model.
RESULTS: Sufficient data were collected to perform a meta-analysis on five current scoring systems: the Pneumonia Severity Index (PSI), the CURB65 score, the CRB65 score, the American Thoracic Society (ATS) 2001 criteria and the Infectious Disease Society of America/ATS (IDSA/ATS) 2007 criteria. The analysis was limited due to large variations in the ICU admission criteria, ICU admission rates and patient characteristics between different studies and different healthcare systems. In the pooled analysis, PSI, CURB65 and CRB65 performed similarly in terms of sensitivity and specificity across a range of cut-offs. Patients in CURB65 group 0 were at lowest risk of ICU admission (negative likelihood ratio 0.14; 95% confidence interval 0.06-0.34) while the ATS 2001 criteria had the highest positive likelihood ratio (7.05; 95% confidence interval 4.39-11.3).
CONCLUSION: Large variations exist in the use of ICU resources between different studies and different healthcare systems. Scoring systems designed to predict 30-day mortality perform less well when ICU admission is taken into account. Further studies of dedicated ICU admission scores are required.

Entities:  

Mesh:

Year:  2011        PMID: 21660535     DOI: 10.1007/s00134-011-2261-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  54 in total

1.  Treatment and outcomes of community-acquired pneumonia at Canadian hospitals.

Authors:  B G Feagan; T J Marrie; C Y Lau; S L Wheeler; C J Wong; M K Vandervoort
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

2.  Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.

Authors:  J D Chalmers; A Singanayagam; A T Hill
Journal:  Thorax       Date:  2008-05-20       Impact factor: 9.139

3.  Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care.

Authors:  C Feldman; S Alanee; V L Yu; G A Richards; A Ortqvist; J Rello; C C C Chiou; M B F Chedid; M M Wagener; K P Klugman
Journal:  Clin Microbiol Infect       Date:  2009-09       Impact factor: 8.067

4.  Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia.

Authors:  C Spindler; A Ortqvist
Journal:  Eur Respir J       Date:  2006-05-31       Impact factor: 16.671

5.  A survey on hospitalised community-acquired pneumonia in Italy.

Authors:  P L Migliorati; E Boccoli; L S Bracci; P Sestini; A S Melani
Journal:  Monaldi Arch Chest Dis       Date:  2006-06

6.  Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.

Authors:  Bertrand Renaud; Eva Coma; Jose Labarere; Jan Hayon; Pierre-Marie Roy; Hélène Boureaux; Fabienne Moritz; Jean François Cibien; Thomas Guérin; Emmanuel Carré; Armelle Lafontaine; Marie Pierre Bertrand; Aline Santin; Christian Brun-Buisson; Michael J Fine; Eric Roupie
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

7.  Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia.

Authors:  M M van der Eerden; C S de Graaff; W Bronsveld; H M Jansen; W G Boersma
Journal:  Respir Med       Date:  2004-09       Impact factor: 3.415

8.  Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.

Authors:  Paschalina Kontou; Joseph L Kuti; David P Nicolau
Journal:  Am J Emerg Med       Date:  2009-10       Impact factor: 2.469

9.  Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study.

Authors:  B Renaud; E Coma; J Hayon; M Gurgui; C Longo; M Blancher; I Jouannic; S Betoulle; E Roupie; M J Fine
Journal:  Clin Microbiol Infect       Date:  2007-07-06       Impact factor: 8.067

10.  New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.

Authors:  S Ewig; N Birkner; R Strauss; E Schaefer; J Pauletzki; H Bischoff; P Schraeder; T Welte; G Hoeffken
Journal:  Thorax       Date:  2009-05-18       Impact factor: 9.139

View more
  37 in total

1.  Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia.

Authors:  Jianjun Wu; Y U Jin; Hailong Li; Zhiping Xie; Jinsong Li; Yuanyun Ao; Zhaojun Duan
Journal:  Exp Ther Med       Date:  2015-05-12       Impact factor: 2.447

2.  A new prediction model for assessing the clinical outcomes of ICU patients with community-acquired pneumonia: a decision tree analysis.

Authors:  Shufang Zhang; Kai Zhang; Yang Yu; Baoping Tian; Wei Cui; Gensheng Zhang
Journal:  Ann Med       Date:  2019-03-23       Impact factor: 4.709

3.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

4.  Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia.

Authors:  Ignacio Martín-Loeches; Jordi Solé-Violán; Felipe Rodríguez de Castro; M Isabel García-Laorden; Luis Borderías; José Blanquer; Olga Rajas; M Luisa Briones; Javier Aspa; Estefanía Herrera-Ramos; José Alberto Marcos-Ramos; Ithaisa Sologuren; Nereida González-Quevedo; José María Ferrer-Agüero; Judith Noda; Carlos Rodríguez-Gallego
Journal:  Intensive Care Med       Date:  2011-11-24       Impact factor: 17.440

5.  Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia.

Authors:  Elena Laserna; Oriol Sibila; Patrick R Aguilar; Eric M Mortensen; Antonio Anzueto; Jose M Blanquer; Francisco Sanz; Jordi Rello; Pedro J Marcos; Maria I Velez; Nivin Aziz; Marcos I Restrepo
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

Review 6.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

7.  How to derive and validate clinical prediction models for use in intensive care medicine.

Authors:  José Labarère; Bertrand Renaud; Renaud Bertrand; Michael J Fine
Journal:  Intensive Care Med       Date:  2014-02-26       Impact factor: 17.440

8.  Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission.

Authors:  Oriol Sibila; G Umberto Meduri; Eric M Mortensen; Antonio Anzueto; Elena Laserna; Juan F Fernandez; Ali El-Sohl; Marcos I Restrepo
Journal:  J Crit Care       Date:  2012-12-21       Impact factor: 3.425

Review 9.  [Community-acquired pneumonia].

Authors:  M Hecker; N Sommer; K Tello; A Hecker; W Seeger; K Mayer
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-04-10       Impact factor: 0.840

Review 10.  Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Christophe Marti; Nicolas Garin; Olivier Grosgurin; Antoine Poncet; Christophe Combescure; Sebastian Carballo; Arnaud Perrier
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.